Vascular development and angiogenesis initially depend on endothelial tip cell invasion, which is followed by a series of maturation steps, including lumen formation and recruitment of perivascular cells. Notch ligands expressed on the endothelium and their cognate receptors expressed on perivascular cells are involved in blood vessel maturation, though little is known regarding the Notch dependent effectors that facilitate perivascular coverage of nascent vessels.
Abstract
Vascular development and angiogenesis initially depend on endothelial tip cell invasion, which is followed by a series of maturation steps, including lumen 
Introduction
The process of angiogenesis must be highly regulated in order to produce a patent vascular system with adequate perfusion to support the surrounding tissue. While multiple cell types, secreted proteins, and growth factors coordinately regulate angiogenesis and vessel stabilization, the Notch signaling pathway is unique in that it is involved at multiple stages of angiogenesis, from initial vascular plexus formation and artery/vein patterning, to vascular smooth muscle cell (VSMC) recruitment and vascular remodeling.
Notch signaling, which is characterized by heterotypic cell-cell interactions between Notch-ligand and -receptor expressing cells, represents an evolutionarily conserved mechanism that is known to be important for cell fate decisions during embryogenesis and, more recently, angiogenesis. Mammals express four Notch receptors, Notch1-4, and five Notch ligands, Delta-like ligand (Dll) 1, Dll3, Dll4, Jagged1 (Jag1), and Jagged2 (Jag2). Notch1, Dll4, and Jag1 are required for vascular development, and genetic deletion of each of these genes results in embryonic lethality [1] [2] [3] [4] [5] . The loss of Notch3, whose expression is restricted primarily to VSMCs in the vasculature, is not lethal, but rather demonstrates that Notch3 is required for arterial differentiation and VSMC maturation 6 . While Notch3 seems to be the critical receptor for mural cell differentiation, Jag1 is the corresponding ligand that has been shown to be most important for this process 7 . Endothelial-specific deletion of Jag1 results in severe mural cell defects, whereas the expression of Jag1 on endothelial cells promotes For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From mural cell differentiation [8] [9] [10] . While there has been research into the role that Notch signaling plays in vessel patterning and VSMC differentiation, the role of Notch signaling in vascular maturation has not been explored because the mouse models used to date are embryonic lethal.
The recruitment of pericytes and VSMCs to nascent vessels is critical to vessel maturation 11 . In the absence of perivascular cell coverage, newly formed vessels are subject to regression and are dependent upon growth factor stimulation from the environment for their survival 12 . However, once invested with pericytes, vessels are stabilized and resistant to regression. One mechanism by which Notch signaling regulates VSMC recruitment to vessels is by the upregulation of In addition to mural cell recruitment, the deposition of an endothelial basement membrane also regulates vessel maturation. Basement membranes are thin layers (50-100 nm) of specialized extracellular matrix shared by endothelial and epithelial cells which provide structure and support for those cells 14 . . Additionally, vWF in the endothelium acts in the recruitment, adhesion, and migration of leukocytes 17, 18 . It has also recently been shown to play a role in vessel patterning 19 . Here we provide evidence that vWF regulates the recruitment of VSMCs to mature arteries.
In this report we identified a novel Notch-downstream effector, integrin 
Material and Methods

In vivo assays
Mouse experiments were performed under approval by the University of California San Diego Institutional Animal Care and Use Committee. Balb/c mice (Jackson Labs) were used for DAPT treatment, anti-CD61 injection, and the vWF/αSMA time course. DiYF mice were a gift from T. Byzova (The Cleveland Clinic) and vWF KO mice were a gift from D. Wagner (Harvard). Both DiYF and vWF KO mice were on a C57BL/6 background, and age-matched C57BL/6 mice (Jackson Labs) were used as controls.
For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From For injection of anti-CD61, postnatal day (P)5 Balb/c pups received a single intravitreal injection of purified NA/LE hamster anti-mouse CD61 (BD Biosciences) (0.5 ug in 0.5 ul volume) using a 2.5 ul Hamilton syringe (Hamilton cat# 87942) fitted with a 33 GA 0.5-inch removable needle (point style 4; Hamilton) into one eye. The contralateral eye received a single injection of purified NA/LE Hamster IgGκ isotype control. Retinas were harvested on day P8
and processed for immunohistochemistry.
phenylglycine t-butylester) (Tocris) was dissolved in 20% DMSO and 80% corn oil (Sigma). Balb/c pups were injected subcutaneously over three consecutive days, at 100 mg/kg in a volume of 10 μl/g daily, either from P2-P5 or from P3-P6.
Whole mount immunohistochemical staining of retinas
Retinas were harvested from postnatal pups aged P1-P28, fixed in 4% PFA for 10 min and dissected in PBS 20 . The retinas were permeabilized in ice-cold methanol for 10 min then blocked in 20% FBS/20% NGS (or 20% NDS)+0.3%
Triton X-100 in PBS for 2 hr. Primary antibodies were added to antibody diluents (10% FBS/10% NGS or 10%NDS) + 0.3% Triton X-100 in PBS) O/N at 4°C. The next day, retinas were washed for 2 hr and secondary antibodies were added.
Primary antibodies: Blood vessels were labeled with either isolectin B4 directly conjugated to Alexa 647 (Invitrogen) or with rat anti-mouse CD31/PECAM-1 (BD Biosciences). VSMCs were labeled with mouse-αSMA directly conjugated to For personal use only. on August 31, 2017 . by guest www.bloodjournal.org From either FITC or Cy3 (Sigma-Aldrich). Other primary antibodies used: rabbit antihuman vWF (Millipore), rabbit anti-NG2 chondroitin sulfate proteoglycan (Millipore), rabbit anti-Jagged1 (Santa Cruz), goat anti-Jagged1 (Santa Cruz), goat anti-Notch3 (Santa Cruz). Secondary antibodies: goat anti-rabbit A568 or A647, goat anti-rat A488, and donkey anti-goat A568 or A647 (Invitrogen). All antibodies were used at a 1:200 dilution.
Immunohistochemistry of retinal frozen sections
Retinas were harvested as described, fixed in 4% PFA in PBS O/N at 4°C, incubated in 20% sucrose in PBS for 2 hr, and embedded in OCT (Tissue-Tek). 
Transmission electron microscopy
Samples were immersed in modified Karnovsky's fixative (1.5% glutaraldehyde, 3% paraformaldehyde and 5% sucrose in 0.1 M sodium cacodylate buffer, pH 7.4) for at least 8 hours, post-fixed in 1% osmium tetroxide in 0.1 M cacodylate buffer for 1 hour and stained en bloc in 1% uranyl acetate for 1 hour. Samples were dehydrated in ethanol, embedded in epoxy resin, sectioned at 60 to 70 nm, and picked up on Formvar and carbon-coated copper grids. Grids were stained with uranyl acetate and lead nitrate, viewed using a JEOL 1200EX II (JEOL, Peabody, MA) transmission electron microscope and photographed using a Gatan digital camera (Gatan, Pleasanton, CA).
Cell culture
HUVECs (Lonza) were cultured in EBM-2 media (Lonza) supplemented with a bullet kit containing endothelial-specific growth factors (Lonza) and 10% FBS (Hyclone). Human aortic vascular smooth muscle cells (VSMCs) from a young donor (Invitrogen, lot #200707) were cultured in Media 231 with smooth muscle cell growth supplement (Invitrogen).
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Jag-1 stimulation of VSMC in vitro
VSMCs between passages 3-7 were cultured on 6-well TCT-dishes coated with 5 μ g/ml IgG or Jagged1 for 18 hr as previously described 13 .
Microarray analysis
VSMCs were cultured on Jag1 or IgG-coated plates as described above. RNA was extracted using RNA isolation kit (Qiagen). Reverse-transcription PCR was done with RNA-to-cDNA kit (Applied Biosystems). cDNA was run on a TaqMan 
Tube formation assay
HUVECs at passage 2 were trypsinized and coated onto Cytodex3 microcarrier beads (GE Healthcare) as previously described 23 . Following overnight culture in EGM-2 (Lonza), HUVEC-coated beads were suspended in fibrinogen (Sigma, 2 mg/ml) with aprotinin (Sigma, 0.15 U/ml) in PBS at a concentration of 500 beads/ml. VSMCs were labeled with DiIC12(3) (1:1000 in culture media for 2 hr; 
Endothelial cell-VSMC co-alignment quantification
The overlap between endothelial cells and VSMCs was taken as a percentage of the endothelial tubes in each image analyzed. To do this, stacks of confocal fluorescent images were analyzed in ImageJ with the RG2B colocalization plugin.
The resultant colocalization images, which show only pixel overlap, were converted to 8-bit images and thresholded. These are the "colocalization"
images. Separately, the corresponding RGB confocal images were split into individual color channels and processed to binary. Of these binary images, the channel of interest is that of the endothelial tubes. These are the "EC tubes"
images. For analyzing colocalization in the bead assay, the pixels corresponding to the beads themselves were deleted from all images analyzed because we were interested in colocalization along the tubes. Finally, the ImageJ "analyze particles" function was run on all images, with the readout being Area Fraction.
To determine colocalization, the following calculation was used: 
siRNA knockdown in VSMC
VSMCs were transfected with siRNAs against Notch3 (Qiagen; Notch3-3) or All Stars control siRNA (Qiagen) using human aortic SMC nucleofector kit (Lonza) in the Amaxa nucleofector system (Lonza) according to manufacturer's instructions.
Knockdown was confirmed by western blot with rabbit anti-Notch3 (Sigma), rabbit anti-Hey2 (ProteinTech Group), mouse anti-HSP60 (Santa Cruz) was used as a loading control.
Statistical analyses
All statistical analyses were performed with Excel (Microsoft). Two-tailed Student's t test was used to calculate statistical significance. A P value < 0.05 was considered to be significant.
Results
Notch is required for VSMC coverage during postnatal angiogenesis
To understand the role of Notch signaling in the perivascular compartment during postnatal developmental angiogenesis, we examined vascular mural cell coverage in the developing mouse retina following pharmacological inhibition of Notch signaling activity. The gamma-secretase inhibitor DAPT blocks the cleavage and release of the intracellular domain of Notch, which is the critical effector that controls gene expression 24 and as such acts as a global Notch inhibitor both in vivo and in vitro 9, 24, 25 . As previously reported 
Endothelial Jag1 is required for arterial VSMC coverage and maintenance
Endothelial cell Jag1, a Notch ligand recognized by VSMCs, is predominantly expressed in the arterial endothelium during murine retinal development 26 (Supplemental Figure 2) and is required for VSMC differentiation during . Genetic ablation of Jag1 from the endothelium of mice using a Tie2-Cre mouse line resulted in embryonic lethality with severe VSMC defects 8 .
To investigate the role of Jag1 in postnatal arterial maturation we used a genetic murine model that bypasses the critical requirement for Jag1 in early endothelial development (VE-Cadherin-Cre; Jag1 ECKO mice) 27 . In the retinas of these mice, we observed weak arterial α SMA + perivascular staining in P7 pups compared to controls, indicating that VSMC recruitment was deficient, leading to less mature arteries during development (Figure 2A , B). Staining with an alternative marker for VSMCs, SM22α, confirmed that it is the VSMC compartment which is affected by loss of endothelial Jag1 (Supplemental Figure   3 ). Pericyte coverage was not affected (Supplemental Figure 4) . In adults, we observed a loss of VSMCs in the arteries immediately adjacent to the Jag1 -endothelium ( Figure 2C-H) . These findings suggest that Jag1 is an endothelial cell Notch ligand capable of regulating arterial maturation and maintaining arteries in a mature state, without loss of VSMCs.
Interaction with Jag1 induces integrin α vβ3 expression on VSMCs
To identify Jag1-dependent Notch-mediated genes that might contribute to arterial maturation, VSMCs were seeded onto plates coated with or without immobilized recombinant Jag1. Eighteen hours later we analyzed changes in gene expression using a low-density array featuring a panel of genes associated with human angiogenesis (Applied Biosystems). Cell interaction with Jag1
For 28, 29 . We confirmed that integrin 
von Willebrand Factor regulates arterial VSMC coverage in vivo
During vascular development both endothelial cells 28 and VSMCs 36 transiently express integrin αvβ3, which is a receptor for von Willebrand Factor (vWF).
Importantly, vWF is an RGD-containing adhesion protein that is unique to the vascular basement membrane 37, 38 . Previous studies have revealed that endothelial cells and VSMCs share a common basement membrane in mature arteries 39, 40 . Since endothelial cells and VSMCs both upregulate integrin ανβ3, a receptor for their shared basement membrane during angiogenesis, we considered whether vWF might regulate VSMC-dependent arterial maturation.
To test this in vivo, we first characterized the vWF expression pattern during retinal development in mice from P1 to P21. Whole-mount staining revealed that vWF accumulated in the endothelial basement membrane during vessel maturation (Supplemental Figure 7) . We observed a strong accumulation in major arteries and veins, but only minimal accumulation in the capillary beds.
During the first month of development, vWF accumulated along arteries in a pattern that completely co-aligned with the perivascular outgrowth of VSMCs (Supplemental Figure 7) . Figure 5A, B) . However, pericyte coverage did not differ between vWF KO and wild type animals (Supplemental Figure 5 ). (Figure 4 ), early defects in developmental angiogenesis were resolved by three weeks of age, suggesting the existence of compensatory/redundancy mechanisms. These finding suggest that vWF regulates an early step in VSMC coverage of developing arteries.
Similar to our observations in DiYF mice
Notch upregulates VSMC adhesion to endothelial vWF via α vβ3
To explore the link between Notch signaling in VSMCs and their adhesion to vWF, VSMCs treated with or without Jag1 were allowed to attach to a vWFcoated substrate in vitro. Jag1-stimulated VSMCs, which upregulate α vβ3 expression ( Figure 3A, B) , showed enhanced adhesion to vWF compared with control cells not exposed to Jag1 (Figure 6A, B) . This increased adhesion could be disrupted by addition of function-blocking antibodies specific to either Figure 6A, B) . Also, inhibition of Notch signaling with DAPT suppressed VSMC adhesion to vWF (Supplemental Figure 8A) . Together, these 
Discussion
Vascular development and angiogenesis depend first on endothelial tip cell invasion, followed by a series of maturation steps, which include recruitment of perivascular cells and the deposition of a mature basement membrane. Notch signaling has been linked to artery/vein patterning 41 , endothelial tip and stalk cell formation 25, 42 , as well as VSMC coverage of newly formed arteries 6, 8 , leading to the formation of functional vascular plexus. However, it is unclear how Notch signaling facilitates vessel maturation, specifically arterial VSMC coverage.
Previous studies have implicated Notch in PDGFRβ expression 13 , a receptor critically involved in pericyte function 43 . In the current study we have identified a new role for Notch that appears to regulate the specific recruitment of VSMCs to maturing arteries.
We present several lines of evidence that Notch signaling is critical for VSMC recruitment to arteries due to its regulation of Vessel maturation, or the lack thereof, has relevance to cancer, diabetic retinopathy, restenosis, wound healing, and stroke, among other pathologies.
During pathological angiogenesis associated with tumor growth, blood vessels lack an intact basement membrane and are highly disorganized, leading to For
